Jefferies Initiates Coverage On City Therapeutics with Buy Rating, Announces Price Target of $32
Benzinga Newsdesk 7 hours ago
Analyst RatingsNewsInitiationPrice Target
Jefferies analyst Maury Raycroft initiates coverage on City Therapeutics (NASDAQ:CTY) with a Buy rating and announces Price Target of $32.
Jefferies analyst Maury Raycroft initiates coverage on City Therapeutics (NASDAQ:CTY) with a Buy rating and announces Price Target of $32.